MGMT and central nervous system cancer: Interestingly, it has been shown that cisplatin treatment can reduce MGMT activity and expression, which is an explanation for the synergism between TMZ and cisplatin.32 Many clinical trials report the combination of TMZ and cisplatin as a valuable alternative for treating refractory and recurrent glioma.33, 34, 35